Author

K. Shindo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. D. Sarca· 1 shared A. Takaori-Kondo· 1 shared E. Stanford· 1 shared H. Matsui· 1 shared H. Yamazaki· 1 shared J. L. Gilmore· 1 shared K. Shirakawa· 1 shared M. Nakano· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Sarca

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

vRNA-vRNA interactions in influenza A virus HA vRNA packaging

S. Miyamoto, Y. Muramoto, K. Shindo, Y. Fujita, T. Morikawa, R. Tamura, J. L. Gilmore, M. Nakano, T. Noda

The paper identifies direct RNA-RNA interactions between HA and PB2 vRNAs in influenza A virus that are critical for selective genome packaging and viral replication.

Journal of Virology · Mar 23, 2022Peer-reviewedMicrobiology

APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression

H. Yamazaki, K. Shirakawa, T. Matsumoto, Y. Kazuma, H. Matsui, Y. Horisawa, E. Stanford, A. D. Sarca, R. Shirakawa, K. Shindo, A. Takaori-Kondo

The paper develops APOBEC3B reporter myeloma cell lines to study DNA damage response pathways that regulate APOBEC3B expression, finding that conventional therapies increase its expression while targeted drugs do not.

bioRxiv · Sep 24, 2019Cancer Biology